A Study of Diabetic Patients With De Novo Native Coronary Artery Lesions

NCT00495898 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DEVICE: CYPHER sirolimus-eluting stent
DEVICE: uncoated Bx VELOCITY balloon-expandable stent

Sponsor

Cordis US Corp.